Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
CoVigilAI is a cutting-edge solution for monitoring medical literature that leverages artificial intelligence and sophisticated data analysis to identify and manage adverse drug reactions proactively, thereby safeguarding patient well-being and adhering to regulatory standards in real time. This platform simplifies the tracking of scientific and medical literature by sourcing information from major global databases like PubMed and Embase, offering customizable search parameters that enhance the pharmacovigilance literature review process. Additionally, it systematically reviews scientific articles and publications from various local journals, ensuring comprehensive global and localized literature oversight. Utilizing advanced algorithms, the system classifies Individual Case Safety Reports (ICSRs) into three categories: valid, potential, and invalid cases, while its automated key entity recognition capability adeptly identifies essential elements such as patients, medications, adverse reactions, and relevant medical events. This holistic approach not only streamlines the monitoring process but also significantly enhances the accuracy and efficiency of drug safety assessments.
Description
DF Literature Monitor is a cutting-edge AI-driven tool that streamlines the process of monitoring extensive literature and enhances safety oversight procedures. It connects with key local and global literature sources to retrieve articles simultaneously, utilizing semantic search technology to efficiently pinpoint pertinent research. The system includes features such as automatic de-duplication, the extraction of essential safety information, and the capability to auto-fill safety case forms, which can be easily submitted to safety databases in E2B or Excel/PDF formats with just one click. Furthermore, it provides automated translation services for abstracts and complete articles into English. DF Literature Monitor is equipped with customizable workflows that promote teamwork and ensure quality control within pharmacovigilance teams. By adopting this solution, organizations can significantly reduce the time and resources spent on literature monitoring by as much as 60% or more, all while maintaining high standards of quality and regulatory compliance. Ultimately, the tool represents a significant advancement in the field of pharmacovigilance, allowing teams to focus on critical analysis rather than manual processes.
API Access
Has API
API Access
Has API
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
CoVigilAI
Country
India
Website
covigilai.in/
Vendor Details
Company Name
Datafoundry
Founded
2016
Country
India
Website
datafoundry.ai/literature-monitor/